XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Changes in Stockholders' Equity
9 Months Ended
Sep. 30, 2024
Changes in Stockholders' Equity  
Changes in Stockholders' Equity

(3)

Changes in Stockholders’ Equity

Three and Nine Months Ended September 30, 2024 (in thousands):

    

    

    

    

    

    

Accumulated

    

    

    

Additional

Other

Total

Common Stock

Paid-In

Comprehensive

Accumulated

Stockholders’

Shares

    

Amount

Capital

Income

Deficit

Equity

Balance, June 30, 2024

179,597

$

17

$

508,971

$

123

$

(386,953)

$

122,158

Issuance of common stock upon exercise of stock options

57

15

15

Issuance of common stock upon release of RSUs

 

1,010

 

 

 

 

 

 

 

 

 

 

Proceeds from sale of common stock through At-The-Market (ATM) Offering

11,294

2

11,996

11,998

Capitalization of deferred costs to equity upon share issuance

(58)

(58)

Stock-based compensation

 

 

3,427

 

 

 

 

 

 

3,427

Foreign currency translation loss

 

 

 

 

 

 

 

61

 

 

 

61

Change in unrealized loss on available-for-sale securities

 

 

 

 

 

 

 

70

 

 

 

 

70

Net loss

 

 

 

 

 

 

 

 

 

(14,833)

 

 

(14,833)

Balance, September 30, 2024

 

191,958

$

19

$

524,351

$

254

$

(401,786)

$

122,838

    

    

    

    

    

    

Accumulated

    

    

    

Additional

Other

Total

Common Stock

Paid-In

Comprehensive

Accumulated

Stockholders’

Shares

    

Amount

Capital

Income

Deficit

Equity

Balance, December 31, 2023

147,066

$

14

$

463,089

$

244

$

(353,759)

$

109,588

Issuance of common stock upon exercise of stock options

307

83

83

Issuance of common stock upon release of RSUs

 

3,810

 

 

 

 

 

 

 

 

 

 

Proceeds from sale of common stock through Purchase Agreement - B. Riley

10,057

 

 

1

 

 

12,837

 

 

 

 

 

 

12,838

Proceeds from sale of common stock through At-The-Market (ATM) Offering

30,718

 

 

4

 

 

38,827

 

 

 

 

 

 

38,831

Capitalization of deferred costs to equity upon share issuance

 

 

 

 

 

(190)

 

 

 

 

 

 

(190)

Stock-based compensation

 

 

 

 

 

9,705

 

 

 

 

 

 

9,705

Foreign currency translation loss

 

 

 

 

 

 

 

(44)

 

 

 

 

(44)

Change in unrealized loss on available-for-sale securities

 

 

 

 

 

 

 

54

 

 

 

 

54

Net loss

 

 

 

 

 

 

 

 

 

(48,027)

 

 

(48,027)

Balance, September 30, 2024

 

191,958

$

19

$

524,351

$

254

$

(401,786)

$

122,838

Three and Nine Months Ended September 30, 2023 (in thousands):

    

    

    

    

    

    

Accumulated

    

    

    

Additional

Other

Total

Common Stock

Paid-In

Comprehensive

Accumulated

Stockholders’

Shares

    

Amount

Capital

Income (loss)

Deficit

Equity

Balance, June 30, 2023

 

132,401

$

13

$

437,320

$

1

$

(318,972)

$

118,362

Issuance of common stock upon exercise of stock options

164

94

94

Issuance of common stock upon exercise of common stock warrants

334

5

5

Issuance of common stock upon release of RSUs

946

Proceeds from sale of common stock through Purchase Agreement - B. Riley

6,336

1

12,702

12,703

Stock-based compensation

3,669

3,669

Foreign currency translation gain

41

41

Change in unrealized loss on available-for-sale securities

32

32

Net loss

(22,215)

(22,215)

Balance, September 30, 2023

 

140,181

$

14

$

453,790

$

74

$

(341,187)

$

112,691

    

    

    

    

    

    

Accumulated

    

    

    

    

Additional

Other

Total

Common Stock

Paid-In

Comprehensive

Accumulated

Stockholders’

Shares

    

Amount

Capital

Income (loss)

Deficit

Equity

Balance, December 31, 2022

 

125,257

$

12

$

429,025

$

(161)

$

(278,652)

$

150,224

Issuance of common stock upon exercise of stock options

3,588

996

996

Issuance of common stock upon exercise of common stock warrants

477

6

6

Issuance of common stock upon release of RSUs

2,654

Proceeds from sale of common stock through Purchase Agreement - B. Riley

8,205

2

15,049

15,051

Capitalization of deferred costs to equity upon share issuance

(13)

(13)

Stock-based compensation

8,727

8,727

Foreign currency translation loss

(38)

(38)

Change in unrealized loss on available-for-sale securities

273

273

Net loss

(62,535)

(62,535)

Balance, September 30, 2023

 

140,181

$

14

$

453,790

$

74

$

(341,187)

$

112,691